|
SLC30A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.375030E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.777300E-04 |
| Normal-vs-Stage2 |
3.221400E-03 |
| Normal-vs-Stage3 |
2.380200E-04 |
| Normal-vs-Stage4 |
2.34149999999156E-05 |
| Stage1-vs-Stage2 |
7.690600E-01 |
| Stage1-vs-Stage3 |
5.321600E-01 |
| Stage1-vs-Stage4 |
9.858100E-02 |
| Stage2-vs-Stage3 |
8.756200E-01 |
| Stage2-vs-Stage4 |
3.494200E-01 |
| Stage3-vs-Stage4 |
3.545600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.988090E-04 |
| Normal-vs-AfricanAmerican |
3.709700E-02 |
| Normal-vs-Asian |
9.842500E-03 |
| Caucasian-vs-AfricanAmerican |
7.457600E-01 |
| Caucasian-vs-Asian |
7.794200E-01 |
| AfricanAmerican-vs-Asian |
9.254200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.86300000005436E-07 |
| Normal-vs-Female |
1.161880E-03 |
| Male-vs-Female |
2.474100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.676700E-03 |
| Normal-vs-Age(41-60Yrs) |
7.88180000000915E-05 |
| Normal-vs-Age(61-80Yrs) |
2.151900E-04 |
| Normal-vs-Age(81-100Yrs) |
2.682400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.308800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.677800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.721000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.911800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.971200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.405600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.647800E-01 |
| Classical-VS-Follicular |
1.422320E-03 |
| Classical-VS-Other |
3.020500E-02 |
| Classical-VS-Normal |
4.817200E-03 |
| Tall-VS-Follicular |
2.555200E-01 |
| Tall-VS-Other |
5.870400E-02 |
| Tall-VS-Normal |
3.421100E-03 |
| Follicular-VS-Other |
2.285200E-01 |
| Follicular-VS-Normal |
5.85819999954218E-07 |
| Other-VS-Normal |
5.155600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.783460E-04 |
| Normal-vs-N1 |
2.622700E-04 |
| N0-vs-N1 |
3.744400E-01 |
|
|
